(Q55461070)

12 July 2018

title

STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma. (English)

1 reference

12 July 2018

0 references

Guo-Shi Lin

1

1 reference

12 July 2018

Li-Juan Yang

2

1 reference

12 July 2018

Xing-Fu Wang

3

1 reference

12 July 2018

Yu-Peng Chen

4

1 reference

12 July 2018

Wen-Long Tang

5

1 reference

12 July 2018

Long Chen

6

1 reference

12 July 2018

Zhi-Xiong Lin

7

1 reference

12 July 2018

publication date

21 March 2014

1 reference

12 July 2018

published in

Medical Oncology

1 reference

12 July 2018

volume

31

1 reference

12 July 2018

issue

4

1 reference

12 July 2018

page(s)

924

1 reference

12 July 2018

The 2007 WHO classification of tumours of the central nervous system

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Stats: transcriptional control and biological impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

STAT signaling in glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

MicroRNAs and STAT interplay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Biology and significance of the JAK/STAT signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Migfilin protein promotes migration and invasion in human glioma through epidermal growth factor receptor-mediated phospholipase C-γ and STAT3 protein signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Activated STAT3 Regulates Hypoxia-Induced Angiogenesis and Cell Migration in Human Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

STAT3 tyrosine phosphorylation influences survival in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Stat3 activation is required for the growth of U87 cell-derived tumours in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

STAT3 silencing inhibits glioma single cell infiltration and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Targeting role of glioma stem cells for glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

A restricted cell population propagates glioblastoma growth after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

STAT3 regulation of glioblastoma pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

STAT3: a critical transcription activator in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0924-5

Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24652192

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-014-0924-5

1 reference

12 July 2018

Dimensions Publication ID

1051254259

0 references

1 reference

12 July 2018